Invesco Ltd. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 201 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2022$34,000
-5.6%
11,855
+0.3%
0.00%
Q4 2021$36,000
-66.7%
11,820
-23.1%
0.00%
Q3 2021$108,000
-8.5%
15,370
+19.8%
0.00%
Q2 2021$118,000
+11.3%
12,825
+18.3%
0.00%
Q1 2021$106,000
-99.2%
10,845
-91.6%
0.00%
-100.0%
Q4 2017$12,796,000
+52.9%
129,447
+85.2%
0.01%
+66.7%
Q3 2017$8,368,000
+426.3%
69,879
+34.9%
0.00%
+200.0%
Q4 2016$1,590,000
+411.3%
51,803
+1207.5%
0.00%
Q4 2015$311,000
-24.3%
3,962
-27.4%
0.00%
Q3 2015$411,000
-91.8%
5,459
-87.3%
0.00%
-100.0%
Q2 2015$5,034,000
-80.6%
43,121
-60.8%
0.00%
-80.0%
Q1 2015$25,951,000
+125.6%
109,910
+80.8%
0.01%
+150.0%
Q4 2014$11,503,000
+72.4%
60,778
+117.3%
0.00%
+33.3%
Q3 2014$6,674,000
+44.6%
27,975
-37.3%
0.00%
+50.0%
Q4 2013$4,616,000
+167.7%
44,589
+38.7%
0.00%
+100.0%
Q3 2013$1,724,00032,1370.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2015
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,417,000$18,010,0002.24%
Palo Alto Investors LP 1,405,680$17,866,0000.87%
PFM Health Sciences, LP 2,838,376$36,076,0000.68%
TANG CAPITAL MANAGEMENT LLC 349,400$4,441,0000.60%
Capital Impact Advisors, LLC 127,029$1,615,0000.59%
Leap Investments LP 29,100$370,0000.50%
Spark Investment Management LLC 454,300$5,774,0000.40%
Partner Investment Management, L.P. 27,567$350,0000.37%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 262,945$3,342,0000.26%
Rock Springs Capital Management LP 534,400$6,792,0000.25%
View complete list of PUMA BIOTECHNOLOGY INC shareholders